-
Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views
Tuesday, May 23, 2023 - 11:19am | 676Read More...Shares of Rain Oncology Inc (NASDAQ: RAIN) recovered in early trading on Tuesday, after having plummeted on disappointing cancer study data. Here are some key analyst takeaways from the company’s decision to halt studies for its lead candidate as a treatment for dedifferentiated (DD)...
-
EF Hutton Reiterates Buy Rating On HCTI, Second Time in 2022
Monday, October 3, 2022 - 8:33am | 1077Read More...On September 28, 2022, Healthcare Triangle Inc (NASDAQ: HCTI) received a Buy rating with a price target of $2.00 in an analyst report by EF Hutton. EF Hutton analyst Constantine Davides, CFA, said “We are reiterating our Buy rating on HCTI. We continue to like the risk-reward of shares here,...
-
SBEV: 2Q Results; Wholesale Wins Should Pave the Way For Continued Top-Line Acceleration
Thursday, August 25, 2022 - 1:41pm | 956Read More...SUMMARY 2Q Results. Splash delivered solid results, with net revenue of $4.5M up 36.8% y/y and 14.6% sequentially. This was driven by its online platform, Qplash as well as the continued rollout of TapOut. Gross margins of 15% contracted 610 bps from a quarter ago due to a handful of one-time...
-
Why This Analyst Feels Sinclair Is A 'Diamond In The Rough'
Tuesday, April 26, 2022 - 10:51am | 291Read More...While Sinclair Broadcast Group Inc (NASDAQ: SBGI) is a diversified media company, providing high-quality content via its local television stations, sports networks and digital platforms, the market seems to be valuing it as a traditional television broadcaster, according to EF Hutton. The Sinclair...
-
Up and Coming Bank Acquires Prestigious Legacy Brand, EF Hutton
Tuesday, June 15, 2021 - 11:18am | 647Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Photo by Anthony DELANOIX on Unsplash As 2021 rolls into the summer, banking, investing, and SPACs are heating up along with the...
-
Who Let The Bear Out At Goldman Sachs?
Wednesday, January 14, 2015 - 3:18pm | 783Read More...Stocks move for a variety of reasons. For most companies outside the biotech and healthcare sector (which move on drug news) earnings and earnings guidance dictate an issue's future direction. Besides earnings related information, ratings changes from investment banks can influence an...






